Elias Papatheodorou is currently the CEO of Genkyotex, a Geneva based clinical stage biotechnology company. Elias has more than 20 years of work experience and Genkyotex is his fifth life sciences company. The previous company he has involved with, Zurich based Covagen, was acquired in 2014 by Jannsen Pharmaceuticals a J&J company. He has been involved in multiple financing, licensing and M&A transactions in Europe, U.S. and Asia. Product candidates he has been involved with are currently in international clinical trials for oncology and inflammatory diseases. He is a frequent speaker at international biotechnology conferences and has served as judge for the EU’s SME funding programs. Elias worked early in his career for The Coca-Cola Company and Philip Morris International. He has received his undergraduate education at Ithaca College and his graduation education at Cornell University.